[ad_1]
The S&P 500’s 3% pullback on Monday doesn’t meet the criteria to be considered a “black swan” event, said author Nassim Nicholas Taleb.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...